Valid Ghana · FDA Ghana

TENORMIN 50MG TABLETS

Atenolo

FDA/SD.255-050755 Atenolo 50mg

What it does

Atenolol is a medication used to manage heart-related conditions.

Commonly used for: high blood pressure (hypertension), chest pain (angina), heart rhythm disorders (arrhythmias)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.255-050755
Registration date
2025-05-14
Expiry date
2030-03-01
Status
Valid
Active ingredient
Atenolo
Dosage form
Atenolo
Strength
50mg
Pack size
-
Therapeutic class
-
Manufacturer / MAH
AstraZeneca
Country of origin
-
Manufacturer location
G9MC+HCV, Jun Shan Lu, 滨湖区 Wu Xi Shi, Jiang Su Sheng, China, 214121

Source: Food and Drugs Authority · fetched 2026-04-18 08:37:11 · updated 2026-10-27 04:00:13

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Atenolol is a medication used to manage heart-related conditions.

What it treats

  • high blood pressure (hypertension)
  • chest pain (angina)
  • heart rhythm disorders (arrhythmias)

How it works

Atenolol helps to lower the heart rate and reduce the workload on the heart, making it easier for the heart to pump blood.

Who it's for

Atenolol is typically prescribed for adults who have high blood pressure or certain heart conditions.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: atenolo

Atenolol is a selective beta-1 adrenergic receptor blocker, primarily used in the management of hypertension, angina pectoris, and for secondary prevention after myocardial infarction. By selectively antagonizing beta-1 receptors in the heart, atenolol reduces heart rate and myocardial contractility, leading to decreased myocardial oxygen demand and improved exercise tolerance in patients with ischemic heart disease.

Indications

  • Hypertension
  • Angina pectoris
  • Myocardial infarction (secondary prevention)
  • Tachyarrhythmias

Dosage

Children: Refer to the BNF for Children for specific dosing information in paediatric patients.

Adults: The usual starting dose for hypertension is 50 mg once daily, which may be adjusted based on blood pressure response. For angina, the starting dose is also commonly 50 mg once daily, with adjustments as necessary.

Mechanism of action

Atenolol works by selectively blocking beta-1 adrenergic receptors located primarily in the heart. This action inhibits the effects of catecholamines (such as adrenaline) on these receptors, resulting in decreased heart rate, reduced force of contraction, and lowered blood pressure. This mechanism helps in controlling heart rate during stress or exercise and is beneficial in conditions like hypertension and angina.

Pharmacodynamics

The pharmacodynamics of atenolol involve its ability to decrease heart rate (negative chronotropic effect), reduce myocardial contractility (negative inotropic effect), and lower blood pressure. The onset of action typically occurs within 1 to 2 hours after oral administration, with peak effects seen within 2 to 4 hours. The duration of action is approximately 24 hours, allowing for once-daily dosing.

Pharmacokinetics

Atenolol is well absorbed following oral administration, with a bioavailability of approximately 50-60%. It has a volume of distribution of about 3-4 L/kg and is primarily eliminated through renal excretion as unchanged drug. The elimination half-life of atenolol is around 6-9 hours, but this may be prolonged in patients with renal impairment. Atenolol does not undergo significant hepatic metabolism, making it a preferred choice in patients with liver disease.

Contra-indications

  • Severe bradycardia
  • Heart block greater than first degree
  • Cardiogenic shock
  • Uncontrolled heart failure
  • Sick sinus syndrome
  • Hypersensitivity to atenolol or any component of the formulation

Adverse effects

  • Fatigue
  • Dizziness
  • Hypotension
  • Bradycardia
  • Cold extremities
  • Gastrointestinal disturbances
  • Sleep disturbances
  • Depression

Interactions

  • Propafenone: Moderate (increases risk of cardiovascular adverse effects)

Precautions

  • Use with caution in patients with asthma or a history of bronchospasm
  • Monitor renal function, particularly in elderly patients
  • May mask signs of hypoglycemia in diabetic patients
  • Caution in patients with peripheral vascular disease

Pregnancy

Atenolol is generally considered to be contraindicated during pregnancy, especially in the third trimester, as it may cause fetal bradycardia and intrauterine growth restriction.

Breast-feeding

Atenolol is excreted in breast milk, and caution is advised when administering to breastfeeding mothers due to potential effects on the nursing infant.

Storage

Store at room temperature, away from moisture and heat. Keep the medication in its original container, tightly closed.

Formulations

  • Tablets: 25 mg, 50 mg, 100 mg
  • Oral solution: 5 mg/mL

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.